Peptide and Anticoagulant Drugs Market 2027 By Type, Application, End User and Geography | The Insight Partners

Peptide and Anticoagulant Drugs Market to 2027 - Global Analysis and Forecasts By Type (Antibiotic, Ace Inhibitors, Antifungal, Hormonal); Application (Diabetes, Infectious Diseases, Cancer, Cardiology, Gynecology, Others); End User (Hospitals and Clinics, Research Institutes, Diagnostics Centers) and Geography

Report Code: TIPRE00006733 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Peptides are represented as a unique category of pharmaceutical ingredients which molecularly composed between small molecules and proteins. The peptides have therapeutic properties that are used to treat various diseases. On the other hand anticoagulant drugs are used to eliminate blood clots and are general kwon as blood thinners. These drugs are used to treat various conditions such as heart disease, problems with blood circulation and others.

MARKET DYNAMICS

The growth of the peptide and anticoagulant drugs market is estimated due to driving factors such as rising incidences of the chronic diseases such as cardiovascular diseases, diabetes, cancer and others. The market is also likely to grow due to the rising demand for the therapeutic drugs to treat the above mentioned conditions. The exponential growth of research and development in the field of pharmaceutical industries is likely to create several growth opportunities for the market.

MARKET SCOPE

The "Global Peptide and Anticoagulant Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of peptide and anticoagulant drugs market with detailed market segmentation by type, application, end user and geography. The global peptide and anticoagulant drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading peptide and anticoagulant drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global peptide and anticoagulant drugs market is segmented on the basis of type, application and end user. Based on the type the market is segmented as antibiotic, ace inhibitors, antifungal, and hormonal. On the basis of application the market is segmented as diabetes, infectious diseases, cancer, cardiology, gynecology, and others. Based on the end user the market is classified as hospitals and clinics, research institutes, diagnostics centers.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global peptide and anticoagulant drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The peptide and anticoagulant drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting peptide and anticoagulant drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the peptide and anticoagulant drugs market in these regions.


MARKET PLAYERS


The reports cover key developments in the peptide and anticoagulant drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from peptide and anticoagulant drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for peptide and anticoagulant drugs market in the global market. Below mentioned is the list of few companies engaged in the peptide and anticoagulant drugs market.

The report also includes the profiles of key peptide and anticoagulant drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott
  •  Wockhardt Ltd.
  •  Baxter
  •  Eli Lilly and Company
  •  Sun Pharmaceutical Industries Ltd.
  •  Dr. Reddy's Laboratories
  •  Teva Pharmaceutical Industries Ltd.
  •  Novartis International AG
  •  Novo Nordisk A/S
  •  Sanofi
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peptide And Anticoagulant Drugs Market - By Type
1.3.2 Peptide And Anticoagulant Drugs Market - By Application
1.3.3 Peptide And Anticoagulant Drugs Market - By End User
1.3.4 Peptide And Anticoagulant Drugs Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PEPTIDE AND ANTICOAGULANT DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PEPTIDE AND ANTICOAGULANT DRUGS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PEPTIDE AND ANTICOAGULANT DRUGS MARKET - GLOBAL MARKET ANALYSIS

6.1. PEPTIDE AND ANTICOAGULANT DRUGS - GLOBAL MARKET OVERVIEW
6.2. PEPTIDE AND ANTICOAGULANT DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PEPTIDE AND ANTICOAGULANT DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE

7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTIBIOTIC
7.3.1. Overview
7.3.2. Antibiotic Market Forecast and Analysis
7.4. ACE INHIBITORS
7.4.1. Overview
7.4.2. Ace Inhibitors Market Forecast and Analysis
7.5. ANTIFUNGAL
7.5.1. Overview
7.5.2. Antifungal Market Forecast and Analysis
7.6. HORMONAL
7.6.1. Overview
7.6.2. Hormonal Market Forecast and Analysis
7.6.3. Insulin Market
7.6.3.1. Overview
7.6.3.2. Insulin Market Forecast and Analysis
7.6.4. Leuprolide Market
7.6.4.1. Overview
7.6.4.2. Leuprolide Market Forecast and Analysis
7.6.5. Teriparatide Acetate Market
7.6.5.1. Overview
7.6.5.2. Teriparatide Acetate Market Forecast and Analysis
7.6.6. Octreotide Acetate Market
7.6.6.1. Overview
7.6.6.2. Octreotide Acetate Market Forecast and Analysis
7.6.7. Glucagon Market
7.6.7.1. Overview
7.6.7.2. Glucagon Market Forecast and Analysis
7.6.8. Others Market
7.6.8.1. Overview
7.6.8.2. Others Market Forecast and Analysis

8. PEPTIDE AND ANTICOAGULANT DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DIABETES
8.3.1. Overview
8.3.2. Diabetes Market Forecast and Analysis
8.4. INFECTIOUS DISEASES
8.4.1. Overview
8.4.2. Infectious Diseases Market Forecast and Analysis
8.5. CANCER
8.5.1. Overview
8.5.2. Cancer Market Forecast and Analysis
8.6. CARDIOLOGY
8.6.1. Overview
8.6.2. Cardiology Market Forecast and Analysis
8.7. GYNECOLOGY
8.7.1. Overview
8.7.2. Gynecology Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis

9. PEPTIDE AND ANTICOAGULANT DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER

9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Research Institutes Market Forecast and Analysis
9.5. DIAGNOSTICS CENTERS
9.5.1. Overview
9.5.2. Diagnostics Centers Market Forecast and Analysis

10. PEPTIDE AND ANTICOAGULANT DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Peptide And Anticoagulant Drugs Market Overview
10.1.2 North America Peptide And Anticoagulant Drugs Market Forecasts and Analysis
10.1.3 North America Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Type
10.1.4 North America Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By End User
10.1.6 North America Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Peptide And Anticoagulant Drugs Market
10.1.6.1.1 United States Peptide And Anticoagulant Drugs Market by Type
10.1.6.1.2 United States Peptide And Anticoagulant Drugs Market by Application
10.1.6.1.3 United States Peptide And Anticoagulant Drugs Market by End User
10.1.6.2 Canada Peptide And Anticoagulant Drugs Market
10.1.6.2.1 Canada Peptide And Anticoagulant Drugs Market by Type
10.1.6.2.2 Canada Peptide And Anticoagulant Drugs Market by Application
10.1.6.2.3 Canada Peptide And Anticoagulant Drugs Market by End User
10.1.6.3 Mexico Peptide And Anticoagulant Drugs Market
10.1.6.3.1 Mexico Peptide And Anticoagulant Drugs Market by Type
10.1.6.3.2 Mexico Peptide And Anticoagulant Drugs Market by Application
10.1.6.3.3 Mexico Peptide And Anticoagulant Drugs Market by End User
10.2. EUROPE
10.2.1 Europe Peptide And Anticoagulant Drugs Market Overview
10.2.2 Europe Peptide And Anticoagulant Drugs Market Forecasts and Analysis
10.2.3 Europe Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Type
10.2.4 Europe Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Peptide And Anticoagulant Drugs Market
10.2.6.1.1 Germany Peptide And Anticoagulant Drugs Market by Type
10.2.6.1.2 Germany Peptide And Anticoagulant Drugs Market by Application
10.2.6.1.3 Germany Peptide And Anticoagulant Drugs Market by End User
10.2.6.2 France Peptide And Anticoagulant Drugs Market
10.2.6.2.1 France Peptide And Anticoagulant Drugs Market by Type
10.2.6.2.2 France Peptide And Anticoagulant Drugs Market by Application
10.2.6.2.3 France Peptide And Anticoagulant Drugs Market by End User
10.2.6.3 Italy Peptide And Anticoagulant Drugs Market
10.2.6.3.1 Italy Peptide And Anticoagulant Drugs Market by Type
10.2.6.3.2 Italy Peptide And Anticoagulant Drugs Market by Application
10.2.6.3.3 Italy Peptide And Anticoagulant Drugs Market by End User
10.2.6.4 Spain Peptide And Anticoagulant Drugs Market
10.2.6.4.1 Spain Peptide And Anticoagulant Drugs Market by Type
10.2.6.4.2 Spain Peptide And Anticoagulant Drugs Market by Application
10.2.6.4.3 Spain Peptide And Anticoagulant Drugs Market by End User
10.2.6.5 United Kingdom Peptide And Anticoagulant Drugs Market
10.2.6.5.1 United Kingdom Peptide And Anticoagulant Drugs Market by Type
10.2.6.5.2 United Kingdom Peptide And Anticoagulant Drugs Market by Application
10.2.6.5.3 United Kingdom Peptide And Anticoagulant Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Peptide And Anticoagulant Drugs Market Overview
10.3.2 Asia-Pacific Peptide And Anticoagulant Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Peptide And Anticoagulant Drugs Market
10.3.6.1.1 Australia Peptide And Anticoagulant Drugs Market by Type
10.3.6.1.2 Australia Peptide And Anticoagulant Drugs Market by Application
10.3.6.1.3 Australia Peptide And Anticoagulant Drugs Market by End User
10.3.6.2 China Peptide And Anticoagulant Drugs Market
10.3.6.2.1 China Peptide And Anticoagulant Drugs Market by Type
10.3.6.2.2 China Peptide And Anticoagulant Drugs Market by Application
10.3.6.2.3 China Peptide And Anticoagulant Drugs Market by End User
10.3.6.3 India Peptide And Anticoagulant Drugs Market
10.3.6.3.1 India Peptide And Anticoagulant Drugs Market by Type
10.3.6.3.2 India Peptide And Anticoagulant Drugs Market by Application
10.3.6.3.3 India Peptide And Anticoagulant Drugs Market by End User
10.3.6.4 Japan Peptide And Anticoagulant Drugs Market
10.3.6.4.1 Japan Peptide And Anticoagulant Drugs Market by Type
10.3.6.4.2 Japan Peptide And Anticoagulant Drugs Market by Application
10.3.6.4.3 Japan Peptide And Anticoagulant Drugs Market by End User
10.3.6.5 South Korea Peptide And Anticoagulant Drugs Market
10.3.6.5.1 South Korea Peptide And Anticoagulant Drugs Market by Type
10.3.6.5.2 South Korea Peptide And Anticoagulant Drugs Market by Application
10.3.6.5.3 South Korea Peptide And Anticoagulant Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Peptide And Anticoagulant Drugs Market Overview
10.4.2 Middle East and Africa Peptide And Anticoagulant Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Peptide And Anticoagulant Drugs Market
10.4.6.1.1 South Africa Peptide And Anticoagulant Drugs Market by Type
10.4.6.1.2 South Africa Peptide And Anticoagulant Drugs Market by Application
10.4.6.1.3 South Africa Peptide And Anticoagulant Drugs Market by End User
10.4.6.2 Saudi Arabia Peptide And Anticoagulant Drugs Market
10.4.6.2.1 Saudi Arabia Peptide And Anticoagulant Drugs Market by Type
10.4.6.2.2 Saudi Arabia Peptide And Anticoagulant Drugs Market by Application
10.4.6.2.3 Saudi Arabia Peptide And Anticoagulant Drugs Market by End User
10.4.6.3 U.A.E Peptide And Anticoagulant Drugs Market
10.4.6.3.1 U.A.E Peptide And Anticoagulant Drugs Market by Type
10.4.6.3.2 U.A.E Peptide And Anticoagulant Drugs Market by Application
10.4.6.3.3 U.A.E Peptide And Anticoagulant Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Peptide And Anticoagulant Drugs Market Overview
10.5.2 South and Central America Peptide And Anticoagulant Drugs Market Forecasts and Analysis
10.5.3 South and Central America Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Type
10.5.4 South and Central America Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America Peptide And Anticoagulant Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Peptide And Anticoagulant Drugs Market
10.5.6.1.1 Brazil Peptide And Anticoagulant Drugs Market by Type
10.5.6.1.2 Brazil Peptide And Anticoagulant Drugs Market by Application
10.5.6.1.3 Brazil Peptide And Anticoagulant Drugs Market by End User
10.5.6.2 Argentina Peptide And Anticoagulant Drugs Market
10.5.6.2.1 Argentina Peptide And Anticoagulant Drugs Market by Type
10.5.6.2.2 Argentina Peptide And Anticoagulant Drugs Market by Application
10.5.6.2.3 Argentina Peptide And Anticoagulant Drugs Market by End User

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. PEPTIDE AND ANTICOAGULANT DRUGS MARKET, KEY COMPANY PROFILES

12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. WOCKHARDT LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAXTER
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY AND COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. DR. REDDY'S LABORATORIES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS INTERNATIONAL AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVO NORDISK A/S
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANOFI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Wockhardt Ltd.
3. Baxter
4. Eli Lilly and Company
5. Sun Pharmaceutical Industries Ltd.
6. Dr. Reddy's Laboratories
7. Teva Pharmaceutical Industries Ltd.
8. Novartis International AG
9. Novo Nordisk A/S
10. Sanofi